You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

PHENYTEK Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Phenytek patents expire, and what generic alternatives are available?

Phenytek is a drug marketed by Mylan and is included in one NDA.

The generic ingredient in PHENYTEK is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Phenytek

A generic version of PHENYTEK was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.

  Start Trial

US Patents and Regulatory Information for PHENYTEK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan PHENYTEK phenytoin sodium CAPSULE;ORAL 040298-002 Dec 6, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan PHENYTEK phenytoin sodium CAPSULE;ORAL 040298-003 Dec 6, 2001 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.